Rapid Advancement Across Core R&D Pipeline The global, multicenter Phase I/II clinical trial of CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) is actively…
WASHINGTON, March 26, 2026 /PRNewswire/ — Inflectra, a leading provider of software testing and quality assurance solutions, today announced the release…